System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Published Erratum Epublish

PubMed: 40925936 DOI: 10.1038/s41467-025-63507-x

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Nat Commun 16(1):8237

Authors: Kate Lawrenson, Siddhartha Kar, Karen McCue, Karoline Kuchenbaeker, Kyriaki Michailidou, Jonathan Tyrer, Jonathan Beesley, Susan J Ramus, Qiyuan Li, Melissa K Delgado, Janet M Lee, Kristiina Aittomäki, Irene L Andrulis, Hoda Anton-Culver, Volker Arndt, Banu K Arun, Brita Arver, Elisa V Bandera, Monica Barile, Rosa B Barkardottir, Daniel Barrowdale, Matthias W Beckmann, Javier Benitez, Andrew Berchuck, Maria Bisogna, Line Bjorge, Carl Blomqvist, William Blot, Natalia Bogdanova, Anders Bojesen, Stig E Bojesen, Manjeet K Bolla, Bernardo Bonanni, Anne-Lise Børresen-Dale, Hiltrud Brauch, Paul Brennan, Hermann Brenner, Fiona Bruinsma, Joan Brunet, Shaik Ahmad Buhari, Barbara Burwinkel, Ralf Butzow, Saundra S Buys, Qiuyin Cai, Trinidad Caldes, Ian Campbell, Rikki Cannioto, Jenny Chang-Claude, Jocelyne Chiquette, Ji-Yeob Choi … and 232 other authors

Affiliations

  • Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, 90033, California, USA.
  • Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, CB1 8RN, UK.
  • QIMR Berghofer Medical Research Institute, Brisbane, 4029, Queensland, Australia.
  • Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, CB1 8RN, UK.
  • Medical College, Xiamen University, Xiamen, 361102, China.
  • Department of Medical Oncology, The Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, 02215, Massachusetts, USA.
  • Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, 00029 HUS, Finland.
  • Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, M5G 1X5, Ontario, Canada.
  • Department of Molecular Genetics, University of Toronto, Toronto, M5S 1A8, Ontario, Canada.
  • Department of Epidemiology, Genetic Epidemiology Research Institute, School of Medicine, University of California Irvine, Irvine, 92697, California, USA.
  • Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
  • University of Texas MD Anderson Cancer Center, Houston, 77030, Texas, USA.
  • Department of Oncology, Karolinska University Hospital, Stockholm, 171 77, Sweden.
  • Cancer Prevention and Control, Rutgers Cancer Institute of New Jersey, New Brunswick, 08903, New Jersey, USA.
  • Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, 20141, Italy.
  • Department of Pathology, Landspitali University Hospital and BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, 600169-2039, Iceland.
  • Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, 91054, Germany.
  • Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, E-28029, Spain.
  • Centro de Investigación en Red de Enfermedades Raras, Valencia, 28029, Spain.
  • Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, 27710, North Carolina, USA.
  • Department of Surgery, Gynecology Service, Memorial Sloan-Kettering Cancer Center, New York, 10065, USA.
  • Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, 5021, Norway.
  • Department of Clinical Science, Centre for Cancer Biomarkers, University of Bergen, Bergen, N-5020, Norway.
  • Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, FIN-00029, Finland.
  • Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, 37203, Tennessee, USA.
  • International Epidemiology Institute, Rockville, 20850, Maryland, USA.
  • Gynaecology Research Unit, Hannover Medical School, Hannover, D-30625, Germany.
  • Department of Clinical Genetics, Vejle Hospital, Vejle, 7100, Denmark.
  • Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, 2200, Denmark.
  • Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, 2730, Denmark.
  • Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, 2730, Denmark.
  • Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, N-0310, Norway.
  • K.G. Jebsen Center for Breast Cancer Research, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, N-0310, Norway.
  • Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, D-70376, Germany.
  • University of Tübingen, Tübingen, 72074, Germany.
  • German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
  • International Agency for Research on Cancer, Lyon, 69008, France.
  • Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, 69121, Germany.
  • Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, 3004, Victoria, Australia.
  • Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, Girona, 08908, Spain.
  • Department of Surgery, National University Health System, Singapore, 119077, Singapore.
  • Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
  • Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, 69120, Germany.
  • Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, 00029 HUS, Finland.
  • Department of Pathology, Helsinki University Central Hospital, Helsinki, 00029, Finland.
  • Department of Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, 84112, Utah, USA.
  • Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, 28040, Spain.
  • Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, 3002, Victoria, Australia.
  • Division of Cancer Prevention and Population Sciences, Cancer Pathology & Prevention, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, 14263, New York, USA.
  • Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, 69121, Germany.
  • University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
  • Unité de recherche en santé des populations, Centre des maladies du sein Deschênes-Fabia, Centre de recherche FRSQ du Centre hospitalier affilié universitaire de Québec, Québec City, G1J 1Z4, Québec, Canada.
  • Cancer Research Institute, Seoul National University, Seoul, 08826, Korea.
  • Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Korea.

MeSH

Biological Science Disciplines, Neoplasms, Ovarian Neoplasms, Breast, Alleles